Skip to main content
AM

Armor Medical Inc

This startup develops a light-based, wrist-worn device that monitors and detects postpartum hemorrhage in real-time. The device helps healthcare institutions enhance patient outcomes and reduce costs by providing continuous monitoring for severe bleeding after childbirth.

Saint Louis, United StatesFounded 2022300+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Postpartum hemorrhage (PPH), or severe blood loss after childbirth, is a leading cause of maternal death globally, with a significant percentage of cases being preventable with early detection and intervention. Current methods for diagnosing PPH often rely on visual estimation of blood loss, which is subjective, inaccurate, and may not detect internal bleeding, leading to late-stage diagnoses and limited treatment options. Existing disparities result in disproportionately higher mortality rates among Black women in the US.

Solution

Armor Medical provides Maternal aRMOR, a wrist-worn wearable device that enables healthcare providers to detect early signs of postpartum hemorrhage through continuous, objective monitoring. The device utilizes patented technology to capture subtle changes in peripheral blood flow, independent of skin pigmentation, which indicate the body's compensatory mechanisms during early hemorrhage. By providing real-time, quantitative insights into a patient's hemorrhage risk, Maternal aRMOR facilitates timely intervention and reduces the reliance on late-stage diagnoses. The solution aims to improve maternal health outcomes, reduce avoidable complications, and address health equity disparities in maternal care.

Target Audience

The primary target audience includes healthcare providers and hospital systems focused on improving maternal health outcomes and reducing postpartum hemorrhage-related complications.

Features

  • Wrist-worn sensor for continuous, non-invasive monitoring of postpartum hemorrhage risk
  • Patented technology that detects subtle changes in peripheral blood flow, independent of skin pigmentation
  • Real-time, quantitative insights into a patient's hemorrhage risk
  • Early detection capabilities, enabling timely intervention and reducing reliance on late-stage diagnoses
  • Aims to reduce avoidable deaths and complications due to hemorrhage by up to 90%
  • Designed to improve maternal and health-equity quality measures
  • Streamlines and automates clinical workflows
This profile is AI-generated and may contain inaccuracies.